Carl Zeiss Meditec AG (CZMWF)
USD 65.07
(12.44%)
USD 65.07
(12.44%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.08 Billion EUR | 9.8% |
| 2022 | 1.9 Billion EUR | 15.55% |
| 2021 | 1.64 Billion EUR | 23.31% |
| 2020 | 1.33 Billion EUR | -8.49% |
| 2019 | 1.45 Billion EUR | 13.93% |
| 2018 | 1.28 Billion EUR | 7.64% |
| 2017 | 1.18 Billion EUR | 9.33% |
| 2016 | 1.08 Billion EUR | 4.64% |
| 2015 | 1.04 Billion EUR | 14.39% |
| 2014 | 909.25 Million EUR | 0.31% |
| 2013 | 906.44 Million EUR | 5.17% |
| 2012 | 861.87 Million EUR | 13.58% |
| 2011 | 758.79 Million EUR | 12.13% |
| 2010 | 676.68 Million EUR | 5.72% |
| 2009 | 640.08 Million EUR | 6.65% |
| 2008 | 600.19 Million EUR | 5.35% |
| 2007 | 569.69 Million EUR | 45.87% |
| 2006 | 390.56 Million EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 947.2 Million EUR | 99.41% |
| 2024 Q1 | 475 Million EUR | -18.06% |
| 2024 Q3 | 539.33 Million EUR | -43.06% |
| 2023 Q4 | 579.7 Million EUR | 8.33% |
| 2023 Q2 | 504.21 Million EUR | 7.21% |
| 2023 Q1 | 470.3 Million EUR | -17.48% |
| 2023 Q3 | 535.12 Million EUR | 6.13% |
| 2023 FY | 2.08 Billion EUR | 9.8% |
| 2022 FY | 1.9 Billion EUR | 15.55% |
| 2022 Q1 | 410.2 Million EUR | -8.56% |
| 2022 Q2 | 445.22 Million EUR | 8.54% |
| 2022 Q3 | 477.49 Million EUR | 7.25% |
| 2022 Q4 | 569.93 Million EUR | 19.36% |
| 2021 Q1 | 368.9 Million EUR | 0.37% |
| 2021 Q4 | 448.58 Million EUR | 4.12% |
| 2021 Q3 | 430.83 Million EUR | 8.13% |
| 2021 Q2 | 398.45 Million EUR | 8.01% |
| 2021 FY | 1.64 Billion EUR | 23.31% |
| 2020 Q2 | 345.25 Million EUR | -6.61% |
| 2020 FY | 1.33 Billion EUR | -8.49% |
| 2020 Q4 | 367.55 Million EUR | 45.29% |
| 2020 Q3 | 252.97 Million EUR | -26.73% |
| 2020 Q1 | 369.7 Million EUR | -14.37% |
| 2019 Q1 | 323.6 Million EUR | -8.73% |
| 2019 Q2 | 343.54 Million EUR | 6.16% |
| 2019 Q3 | 360.41 Million EUR | 4.91% |
| 2019 Q4 | 431.72 Million EUR | 19.78% |
| 2019 FY | 1.45 Billion EUR | 13.93% |
| 2018 FY | 1.28 Billion EUR | 7.64% |
| 2018 Q1 | 294.7 Million EUR | -9.38% |
| 2018 Q2 | 318.95 Million EUR | 8.23% |
| 2018 Q3 | 312.6 Million EUR | -1.99% |
| 2018 Q4 | 354.56 Million EUR | 13.42% |
| 2017 Q4 | 325.19 Million EUR | 17.31% |
| 2017 Q3 | 277.21 Million EUR | -9.85% |
| 2017 Q2 | 307.48 Million EUR | 9.82% |
| 2017 Q1 | 280 Million EUR | -3.37% |
| 2017 FY | 1.18 Billion EUR | 9.33% |
| 2016 Q1 | 262.6 Million EUR | -9.87% |
| 2016 Q3 | 257.81 Million EUR | -7.32% |
| 2016 Q4 | 289.76 Million EUR | 12.39% |
| 2016 FY | 1.08 Billion EUR | 4.64% |
| 2016 Q2 | 278.18 Million EUR | 5.93% |
| 2015 FY | 1.04 Billion EUR | 14.39% |
| 2015 Q4 | 291.36 Million EUR | 16.2% |
| 2015 Q2 | 256.86 Million EUR | 6.54% |
| 2015 Q1 | 241.09 Million EUR | 2.36% |
| 2015 Q3 | 250.74 Million EUR | -2.38% |
| 2014 Q2 | 248.64 Million EUR | 17.13% |
| 2014 FY | 909.25 Million EUR | 0.31% |
| 2014 Q4 | 235.53 Million EUR | 10.68% |
| 2014 Q3 | 212.8 Million EUR | -14.42% |
| 2014 Q1 | 212.27 Million EUR | -17.53% |
| 2013 Q1 | 218.99 Million EUR | -5.22% |
| 2013 FY | 906.44 Million EUR | 5.17% |
| 2013 Q2 | 223.95 Million EUR | 2.26% |
| 2013 Q3 | 206.08 Million EUR | -7.98% |
| 2013 Q4 | 257.4 Million EUR | 24.9% |
| 2012 Q4 | 231.05 Million EUR | 16.1% |
| 2012 Q1 | 210.34 Million EUR | 3.47% |
| 2012 FY | 861.87 Million EUR | 13.58% |
| 2012 Q3 | 199.01 Million EUR | -10.13% |
| 2012 Q2 | 221.45 Million EUR | 5.28% |
| 2011 Q3 | 179.45 Million EUR | -5.95% |
| 2011 Q1 | 185.24 Million EUR | -0.33% |
| 2011 Q2 | 190.8 Million EUR | 3.0% |
| 2011 Q4 | 203.29 Million EUR | 13.29% |
| 2011 FY | 758.79 Million EUR | 12.13% |
| 2010 FY | 676.68 Million EUR | 5.72% |
| 2010 Q2 | 164.91 Million EUR | 5.56% |
| 2010 Q3 | 169.68 Million EUR | 2.89% |
| 2010 Q4 | 185.85 Million EUR | 9.53% |
| 2010 Q1 | 156.22 Million EUR | -3.3% |
| 2009 Q2 | 158.84 Million EUR | -10.71% |
| 2009 Q3 | 141.78 Million EUR | -10.74% |
| 2009 FY | 640.08 Million EUR | 6.65% |
| 2009 Q4 | 161.55 Million EUR | 13.94% |
| 2009 Q1 | 177.9 Million EUR | 0.0% |
| 2008 FY | 600.19 Million EUR | 5.35% |
| 2007 FY | 569.69 Million EUR | 45.87% |
| 2006 FY | 390.56 Million EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -65365.048% |
| Ansell Limited | 1.61 Billion USD | -29.025% |
| Ansell Limited | 1.61 Billion USD | -29.025% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -1031.507% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -1546899.371% |
| Psykey, Inc. | 419.29 Thousand USD | -498184.041% |
| ConvaTec Group Plc | 2.19 Billion USD | 4.773% |
| ConvaTec Group Plc | 2.14 Billion USD | 2.479% |
| Encision Inc. | 6.58 Million USD | -31623.921% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -114386.897% |
| LifePoint, Inc. | -18.5 Thousand USD | 11293613.514% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -30566.373% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -270534.715% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -211749.283% |
| Reflect Scientific, Inc. | 1.08 Million USD | -193326.123% |
| SmileDirectClub, Inc. | 470.74 Million USD | -343.83% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -11.631% |
| SheerVision, Inc. | 3.49 Million USD | -59604.401% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -150611.177% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -280307.949% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -2003390.502% |